Azelastine 0.1% (137 MCG) spry 30ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM9B9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,462
Award facts
- Contract value 100% obligated
- $2,461.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,461.70 to AmerisourceBergen Drug Corp for the supply of Azelastine 0.1% (137 micrograms) nasal spray in 30-milliliter units. This competitively awarded, firm fixed-price delivery order was issued on January 7, 2026, with an ultimate completion date of January 8, 2026. The product will be delivered to the place of performance in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the vehicle for this and similar pharmaceutical supply orders to military healthcare programs globally.
The award reflects AmerisourceBergen's established role as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and military treatment facilities. Azelastine is an antihistamine nasal spray commonly used for allergic rhinitis treatment in clinical settings. No set-aside designation was applied to this award, indicating full and open competition. The delivery order represents a routine pharmaceutical supply transaction within the broader scope of the company's comprehensive IDC with DLA, which encompasses a wide range of prescription medications, generic drugs, vaccines, medical devices, and specialized healthcare commodities required across military and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FM9B9?
SPE2DR26FM9B9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FM9B9 worth?
The government has obligated $2,462 on SPE2DR26FM9B9.
Is contract SPE2DR26FM9B9 an order under another contract?
Yes. SPE2DR26FM9B9 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM9B9 competed?
The extent of competition for SPE2DR26FM9B9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award